Biologically Responsive Nanosystems Targeting Cardiovascular Diseases Therapy

被引:1
|
作者
Song, Zhiling [1 ,2 ]
Song, Kechen [1 ,2 ]
Xiao, Yi [1 ,2 ]
Guo, Hui [3 ]
Zhu, Yizhun [1 ,2 ]
Wang, Xiaolin [1 ,2 ]
机构
[1] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Taipa 999078, Macao, Peoples R China
[2] Macau Univ Sci & Technol, Sch Pharm, Taipa, Macao, Peoples R China
[3] Sun Yat Sen Univ, Sch Chem Engn & Technol, Zhuhai, Peoples R China
关键词
Biologically responsive; nanosystems; nanoparticle; drug delivery; stimuli-triggered drug release; cardiovascular diseases; HIGH-DENSITY-LIPOPROTEIN; DRUG-DELIVERY SYSTEMS; MATRIX-METALLOPROTEINASE; ATHEROSCLEROTIC PLAQUES; GOLD NANOPARTICLES; GLOBAL BURDEN; PLASMINOGEN-ACTIVATOR; SILICA NANOPARTICLES; OXIDATIVE STRESS; GENE DELIVERY;
D O I
10.2174/1567201818666210127093743
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cardiovascular Diseases (CVD) remain the leading cause of mortality and morbidity worldwide. To date, significant progress has been made in developing stimuli-responsive nanosystems that can intrinsically interact with pathological microenvironment to achieve site-specific delivery along with on-demand drug release for precise CVD treatment. Herein, this review summarizes recent advances on smart nanosystems in response to a wide range of biological cues, including pH, enzymes, ROS, shear force, ATP, etc., which can boost drug delivery performance or monitor disease progression in a non-invasive manner. The designs, compositions and main outcomes of the single and multi-responsive nanosystems for drug delivery and/or detection purposes are provided and discussed.
引用
收藏
页码:880 / 901
页数:22
相关论文
共 50 条
  • [31] Gene therapy for cardiovascular diseases
    Gruchala, M
    Roy, H
    Bhardwaj, S
    Ylä-Herttuala, S
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (04) : 407 - 423
  • [32] Diabetes therapy and cardiovascular diseases
    Mannucci, Edoardo
    GIORNALE ITALIANO DI CARDIOLOGIA, 2016, 17 (03) : 3S - 4S
  • [33] Antisense Therapy for Cardiovascular Diseases
    Phillips, M. Ian
    Costales, Jessica
    Lee, Robert J.
    Oliveira, Edilamar
    Burns, Andrew B.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (30) : 4417 - 4426
  • [34] Rapid Development of Targeting circRNAs in Cardiovascular Diseases
    Zhang, Chao
    Huo, Si Tong
    Wu, Zhiyonf
    Chen, Lina
    Wen, Chang
    Chen, Honghao
    Du, William W.
    Wu, Nan
    Guan, Daogang
    Lian, Sen
    Yang, Burton B.
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2020, 21 : 568 - 576
  • [35] Therapeutic Potential of EVs: Targeting Cardiovascular Diseases
    Frances, Javier Laura
    Pagiatakis, Christina
    Di Mauro, Vittoria
    Climent, Montserrat
    BIOMEDICINES, 2023, 11 (07)
  • [36] Targeting metabolic pathways to treat cardiovascular diseases
    Glatz, Jan F. C.
    Zuurbier, Coert J.
    Larsen, Terje S.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (10):
  • [37] Targeting regulatory T cells for cardiovascular diseases
    Wang, Xinting
    Zhou, Hua
    Liu, Qian
    Cheng, Peipei
    Zhao, Tingyao
    Yang, Tianshu
    Zhao, Yue
    Sha, Wanjing
    Zhao, Yanyan
    Qu, Huiyan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [38] Targeting Endogenous Antioxidants to Prevent Cardiovascular Diseases
    Tang, W. H. Wilson
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2012, 1 (06):
  • [39] Targeting the apelin system for the treatment of cardiovascular diseases
    Chapman, Fiona A.
    Maguire, Janet J.
    Newby, David E.
    Davenport, Anthony P.
    Dhaun, Neeraj
    CARDIOVASCULAR RESEARCH, 2023, 119 (17) : 2683 - 2696
  • [40] Ischemic Microenvironment-Responsive Therapeutics for Cardiovascular Diseases
    Li, Xi
    Zhang, Yabing
    Ren, Xiangyi
    Wang, Yan
    Chen, Dongxu
    Li, Qian
    Huo, Minfeng
    Shi, Jianlin
    ADVANCED MATERIALS, 2021, 33 (52)